Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Reneuron Group
Reneuron Group
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Reneuron Group
Stock Price
£0
2024-08-30
Market Capitalization
£1.9 M
2024-08-30
Revenue
£849 K
FY, 2025
Reneuron Group Summary
Company Summary
Overview
ReNeuron is a leading, UK-based stem cell company. Our primary objective is the development of stem cell therapies targeting areas of significant unmet or poorly met medical need
Type
Public
Status
Active
Founded
1997
HQ
Pencoed, GB
|
view all locations
Website
http://www.reneuron.com/
Cybersecurity rating
ESG rating
30-39 out of 100
|
View all ESG data
Sectors
Healthcare
biotech
genetics
Homepage
Linkedin
Table of Contents
Key People
Locations
Financials
Competitors
Key People
Iain Ross,
Executive Chairman
John Hawkins,
Chief Financial Officer and Director
Linkedin
Randolph Corteling,
Chief Scientific Officer
Linkedin
Suzanne Hancock,
Chief Operations Officer
Linkedin
and 5 others
Locations
View all
1 location detected
Pencoed, Wales
HQ
United Kingdom
Reneuron Group Financials
Summary Financials
Revenue (FY, 2025)
£849.0K
Gross profit (FY, 2025)
£849.0K
Net income (FY, 2025)
£782.0K
Cash (FY, 2025)
£513.0K
EBIT (FY, 2025)
£734.0K
Competitors and Similar Companies
Blueprint Genetics
Healthcare - Private
Tessera Therapeutics
Healthcare - Private
Poseida Therapeutics
Healthcare - Public
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
Healthcare - Public
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top